OASMIA PHARMACEUT. SK-,10
OASMIA PHARMACEUT. SK-,10
Share · SE0000722365 · 509722 (XSTO)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - 0,00 % 0,00 % -14,92 % -14,92 % -66,02 %

Company Profile for OASMIA PHARMACEUT. SK-,10 Share

Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.

Company Data

Name OASMIA PHARMACEUT. SK-,10
Company Vivesto AB
Website https://www.vivesto.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN 509722
ISIN SE0000722365
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mr. Erik Kinnman Assoc. Prof., M.B.A., M.D., Ph.D.
Market Capitalization 142 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Gustav III:s Boulevard 46, 169 73 Solna
IPO Date 2005-01-01

Ticker Symbols

Name Symbol
Frankfurt OMAX.F
London 0N4A.L

More Shares

Investors who OASMIA PHARMACEUT. SK-,10 hold also have the following shares in their portfolio:
AF-GL EQ.SU.IN.A2QTIUHEOD
AF-GL EQ.SU.IN.A2QTIUHEOD Fund
FS KKR CAP. 24/29
FS KKR CAP. 24/29 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025